19-10783059-C-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001005361.3(DNM2):c.788C>A(p.Pro263Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P263L) has been classified as Benign.
Frequency
Consequence
NM_001005361.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant centronuclear myopathyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease dominant intermediate BInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- autosomal dominant Charcot-Marie-Tooth disease type 2MInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fetal akinesia-cerebral and retinal hemorrhage syndromeInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary spastic paraplegiaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNM2 | NM_001005361.3 | c.788C>A | p.Pro263Gln | missense_variant | Exon 6 of 21 | ENST00000389253.9 | NP_001005361.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNM2 | ENST00000389253.9 | c.788C>A | p.Pro263Gln | missense_variant | Exon 6 of 21 | 5 | NM_001005361.3 | ENSP00000373905.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250528 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461552Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727076 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.P263Q variant (also known as c.788C>A), located in coding exon 6 of the DNM2 gene, results from a C to A substitution at nucleotide position 788. The proline at codon 263 is replaced by glutamine, an amino acid with similar properties. This variant has been detected in individuals with Charcot-Marie-Tooth (CMT) disease, some of whom had causative mutations in other CMT-associated genes; in addition, this alteration has been detected in healthy control individuals (Choi BO et al. Hum Mutat, 2012 Nov;33:1610-5; Antoniadi T et al. BMC Med Genet, 2015 Sep;16:84). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at